1. Moore MA, Tajima K, Anh PH, Aydemir G, Basu PS, Bhurgri Y, Chen K, Gajalakshmi V, Hirose K, Jarrahi AM, le Ngoan T, Qiao YL, Shin HR, Sriamporn S, Srivatanakul P, Tokudome S, Yoo KY, Tsuda H (2003) Grand challenges in global health and the practical prevention program? Asian focus on cancer prevention in females of the developing world. Asian Pac J Cancer Prev 4:153–165
2. Umezulike AC, Tabansi SN, Ewunonu HA, Nwana EJ (2007) Epidemiological characteristics of carcinoma of the cervix in the Federal capital Territory of Nigeria. Niger J Clin Pract 10:143–146
3. Ronco G, Anttila A (2009) Cervical cancer screening in Europe—changes over the last 9 years. Eur J Cancer 45:2629–2631
4. Hoshida Y, Villanueva A, Kobayashi M, Peix J, Chiang DY, Camargo A, Gupta S, Moore J, Wrobel MJ, Lerner J, Reich M, Chan JA, Glickman JN, Ikeda K, Hashimoto M, Watanabe G, Daidone MG, Roayaie S, Schwartz M, Thung S, Salvesen HB, Gabriel S, Mazzaferro V, Bruix J, Friedman SL, Kumada H, Llovet JM, Golub TR (2008) Gene expression in fixed tissues and outcome in hepatocellular carcinoma. N Engl J Med 359:1995–2004
5. Baritaki S, Sifakis S, Huerta-Yepez S, Neonakis IK, Soufla G, Bonavida B, Spandidos DA (2007) Overexpression of VEGF and TGF-beta1 mRNA in Pap smears correlates with progression of cervical intraepithelial neoplasia to cancer: implication of YY1 in cervical tumorigenesis and HPV infection. Int J Oncol 31:69–79